Indoleamine-2,3-Dioxygenase in Thyroid Cancer Cells Suppresses Natural Killer Cell Function by Inhibiting NKG2D and NKp46 Expression via STAT Signaling Pathways
暂无分享,去创建一个
Haiyoung Jung | Mi Sun Kim | I. Choi | Hee-Gu Lee | Yunhee Lee | S. Yoon | Tae-Don Kim | Young-Jun Park | Yunjeong Yang | A. Park
[1] É. Vivier,et al. Natural killer cells and other innate lymphoid cells in cancer , 2018, Nature Reviews Immunology.
[2] Haiyoung Jung,et al. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation , 2018, Front. Immunol..
[3] P. Xue,et al. The Aryl Hydrocarbon Receptor and Tumor Immunity , 2018, Front. Immunol..
[4] K. Satyshur,et al. Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR) , 2017, The Journal of Biological Chemistry.
[5] V. Sexl,et al. STATs in NK-Cells: The Good, the Bad, and the Ugly , 2017, Front. Immunol..
[6] C. Tremblay,et al. Kynurenine Reduces Memory CD4 T-Cell Survival by Interfering with Interleukin-2 Signaling Early during HIV-1 Infection , 2016, Journal of Virology.
[7] N. Cacalano. Regulation of Natural Killer Cell Function by STAT3 , 2016, Front. Immunol..
[8] J. Routy,et al. The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy , 2016, International journal of tryptophan research : IJTR.
[9] Zhiyu Li,et al. Research progress of indoleamine 2,3-dioxygenase inhibitors. , 2015, Future medicinal chemistry.
[10] W. Wick,et al. Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors , 2015, Front. Immunol..
[11] V. Poli,et al. Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance. , 2014, Blood.
[12] É. Vivier,et al. Natural cytotoxicity receptors and their ligands , 2014, Immunology and cell biology.
[13] A. von Deimling,et al. Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR , 2014, Oncotarget.
[14] M. Veldhoen,et al. The aryl hydrocarbon receptor in innate T cell immunity , 2013, Seminars in Immunopathology.
[15] H. Rosen,et al. Natural killer cells: multifaceted players with key roles in hepatitis C immunity , 2013, Immunological reviews.
[16] K. Kataoka,et al. The ARNT–STAT3 axis regulates the differentiation of intestinal intraepithelial TCRαβ+CD8αα+ cells , 2013, Nature Communications.
[17] D. Munn,et al. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. , 2013, Trends in immunology.
[18] C. Biron,et al. Changing partners at the dance , 2013, JAK-STAT.
[19] P. Queirolo,et al. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. , 2012, Cancer research.
[20] A. Kimura,et al. Aryl hydrocarbon receptor negatively regulates LPS-induced IL-6 production through suppression of histamine production in macrophages. , 2011, International immunology.
[21] X. Pivot,et al. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells. , 2011, Cancer research.
[22] Dean Anthony Lee,et al. Expansion, purification, and functional assessment of human peripheral blood NK cells. , 2011, Journal of visualized experiments : JoVE.
[23] H. Weiner,et al. The Aryl hydrocarbon Receptor (AhR) interacts with c-Maf to promote the differentiation of IL-27-induced regulatory type 1 (TR1) cells , 2010, Nature Immunology.
[24] P. Queirolo,et al. Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity , 2009, Proceedings of the National Academy of Sciences.
[25] B. Stockinger,et al. The aryl hydrocarbon receptor in immunity. , 2009, Trends in immunology.
[26] O. Mazda,et al. Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity. , 2009, Cancer research.
[27] M. Veldhoen,et al. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells , 2009, The Journal of experimental medicine.
[28] Y. Fujii‐Kuriyama,et al. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells , 2008, Proceedings of the National Academy of Sciences.
[29] J. Becker,et al. Macrophage Migration Inhibitory Factor Contributes to the Immune Escape of Ovarian Cancer by Down-Regulating NKG2D1 , 2008, The Journal of Immunology.
[30] Eric Vivier,et al. Functions of natural killer cells , 2008, Nature Immunology.
[31] A. Diefenbach,et al. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. , 2007, Immunity.
[32] G. Rabinovich,et al. Immunosuppressive strategies that are mediated by tumor cells. , 2007, Annual review of immunology.
[33] Sun-Hee Kim,et al. Novel Compound 2-Methyl-2H-pyrazole-3-carboxylic Acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) Prevents 2,3,7,8-TCDD-Induced Toxicity by Antagonizing the Aryl Hydrocarbon Receptor , 2006, Molecular Pharmacology.
[34] L. Lanier,et al. IL-21 Enhances Tumor Rejection through a NKG2D-Dependent Mechanism1 , 2005, The Journal of Immunology.
[35] J. D. Di Santo,et al. Roles for Common Cytokine Receptor γ-Chain-Dependent Cytokines in the Generation, Differentiation, and Maturation of NK Cell Precursors and Peripheral NK Cells in Vivo1 , 2005, The Journal of Immunology.
[36] S. Kitano,et al. Inhibition of indoleamine 2,3-dioxygenase suppresses NK cell activity and accelerates tumor growth. , 2003, Journal of experimental therapeutics & oncology.
[37] R. Biassoni,et al. Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] Kazuyoshi Takeda,et al. New aspects of natural-killer-cell surveillance and therapy of cancer , 2002, Nature Reviews Cancer.
[39] G. Damonte,et al. Tryptophan-derived Catabolites Are Responsible for Inhibition of T and Natural Killer Cell Proliferation Induced by Indoleamine 2,3-Dioxygenase , 2002, The Journal of experimental medicine.
[40] Gerhard Opelz,et al. Inhibition of Allogeneic T Cell Proliferation by Indoleamine 2,3-Dioxygenase–expressing Dendritic Cells , 2002, The Journal of experimental medicine.
[41] P. Bucher,et al. DNA Binding Specificity of Different STAT Proteins , 2001, The Journal of Biological Chemistry.
[42] C. O'Callaghan. Molecular basis of human natural killer cell recognition of HLA-E (human leucocyte antigen-E) and its relevance to clearance of pathogen-infected and tumour cells. , 2000, Clinical science.
[43] J. Ritz,et al. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. , 2000, Blood.
[44] U. Hadding,et al. Interferon-γ-Induced Activation of Indoleamine 2,3-Dioxygenase in Cord Blood Monocyte-Derived Macrophages Inhibits the Growth of Group B Streptococci , 1998 .
[45] J. Darnell. STATs and gene regulation. , 1997, Science.
[46] T. Hoey,et al. Cooperative DNA Binding and Sequence-Selective Recognition Conferred by the STAT Amino-Terminal Domain , 1996, Science.
[47] Milton W. Taylor,et al. Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] M. Edelstein,et al. Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[49] K. Kataoka,et al. The ARNT-STAT3 axis regulates the differentiation of intestinal intraepithelial TCR alpha beta(+) CD8 alpha alpha(+) cells , 2013 .
[50] E. Jaffee,et al. Mechanisms of immune evasion by tumors. , 2006, Advances in immunology.
[51] W. Leonard,et al. The Jak-STAT pathway. , 2000, Molecular immunology.
[52] U. Hadding,et al. Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. , 1998, The Journal of infectious diseases.
[53] L. Lanier. NK cell receptors. , 1998, Annual review of immunology.
[54] J. Darnell,et al. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.